glp 1 agonist osteoporosis A study presented at the #AAOS2026 Annual Meeting revealed GLP-1 receptor use was associated with a 29% higher risk of after five years. As these medications become more widely used, GLP-1 receptor agonists could protect

Now it has been shown that limited experimental data can be used to train sophisticated machine learning models to accurately predict the activity of previously uncharacterized peptide ligand variants.

Satiety regulation (reduces appetite, aiding in weight loss)

Partly through these actions, GLP-1 receptor agonism was shown to reduce cardiovascular disease (CVD) in people with T2D with previous CVD or at high-risk thereof

Lets explore each type of medication in more detail.

About one in eight adults (12%) say they have taken one of an increasingly popular class of prescription drugs known as GLP-1s that are used for weight loss and to treat diabetes and reduce the risk of heart disease and stroke, a new KFF Health Tracking Poll finds.

Allulose is a rare sugar that may modestly support GLP-1 secretion through gut hormone pathways, but dietary changes alone rarely match the effect of prescription GLP-1 therapy